oral GLP-1R class B GCPR agonist
oral glucose-lowering activity observed in HV
from sensitized cell HTS of 2.8M cmpds + opt.
bioRxiv, Sep. 30, 2020
Pfizer, Cambridge, MA / Groton, CT
PF-06882961 is an oral small molecule agonist of the glucagon-like peptide-1 receptor (GLP-1R). GLP-1R agonists increase the production of insulin and are highly useful in the treatment of diabetes. However,…